General Information of Drug Formulation (ID: F02047)

Formulation Name
Atorvastatin 40 mg tablet
Company
Aphena Pharma Solutions-Tennessee; Avera McKennan Hospital; Mylan Pharamceuticals
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Arginine E00112 6322 Buffering agent; Dispersing agent
Beta-D-lactose E00099 6134 Diluent; Dry powder inhaler carrier; Lyophilization aid
Carbonic acid disodium salt E00199 10340 Alkalizing agent; Buffering agent; Diluent; Dispersing agent
Carmellose sodium E00625 Not Available Disintegrant
Magnesium stearate E00208 11177 lubricant
Polyvinyl alcohol E00666 Not Available Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Silicon dioxide E00670 Not Available Anticaking agent; Opacifying agent; Viscosity-controlling agent
Soybean lecithin E00637 Not Available Other agent
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent